GHW International
GHW International (9933.HK) Stock Overview
Explore GHW International’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.4B
P/E Ratio
102.13
EPS (TTM)
$0.01
ROE
0.02%
9933.HK Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of GHW International (9933.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $6.65.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 102.13 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
GHW International, an investment holding company, manufactures and sells chemical and pharmaceutical products in the People's Republic of China, Europe, Vietnam, rest of Asia, and internationally. It operates through four segments: Polyurethane Materials, Animal Nutrition Chemicals, Fine Chemicals, and Pharmaceutical Products and Intermediates. The Polyurethane Materials segment offers polymeric methylene diphenyl diisocyanate and toluene diisocyanate, and polymer polyether for use in cushion foams, interior components, and other lightweight automotive parts. The Animal Nutrition Chemicals segment provides choline chloride and betaine used in feeds for poultry and livestock. The Fine Chemicals segment offers carboxylic acids, solvents, resins, and oleochemicals used in the paint and synthesis of dyes, production of lubricants, emulsifiers, cosmetics, flavors and fragrances, and feed additives. The Pharmaceutical Products and Intermediates segment produces and sells isooctanoic acid and diethyl sulfate for use in paint drier, fungicide, preservative and pharmaceutical raw materials, synthesis of dyes, pesticides, and pharmaceutical intermediates; and iodine and iodine derivatives, and pharmaceutical products, such as cefpodoxime dispersible tablets. GHW International was founded in 1995 and is headquartered in Nanjing, the People's Republic of China.
Yanbin Yin
1,120
6th Building, Nanjing
2020